Schedule 13G ownership disclosure

Freeline Therapeutics Holdings plc

Security class unavailable · CUSIP: 35655L107

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,521,586
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000001
Form type
SC 13G
Filer
Freeline Therapeutics Holdings plc
CIK
CIK 1810031
Filed
Jan 11, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub